Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cambridge Advisory Group is a U.S.-based healthcare, pharmacy, actuarial, and employee benefits consulting firm rather than a drug development biotech company. The business provides employers and other clients with health and welfare consulting, pharmacy benefit analysis, retirement consulting, actuarial services, and data-driven advisory support. Founded in 1999, the company built a reputation around analytics-driven benefit strategy and captive-related consulting. In March 2022, Cambridge Advisory Group was acquired by Risk Strategies and now operates as a division within that organization. It is healthcare-related through benefits, pharmacy, and population health advisory services, but it does not appear to maintain a therapeutic product pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cambridge Advisory Group.